The future of chemotherapy of prostatic cancer
Grillo-López, A.J.; Vélez-García, E.
Boletin de la Asociacion Medica de Puerto Rico 67(11): 327-330
1975
ISSN/ISBN: 0004-4849 PMID: 1060454 Document Number: 700760
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356Stoter, G.; Jones, W.G. 1988: Chemotherapy of hormone refractory prostatic cancer Progress in Clinical and Biological Research 260: 123-125
Nikolaev, A.A.; Lutskiĭ, D.L.; Nikolaeva, N.N. 2000: Prostatic cancer: immunochemical control over chemotherapy Urologiia 3: 41-43
Murphy, G.P. 1987: To what degree is chemotherapy useful in the treatment of prostatic cancer Progress in Clinical and Biological Research 243b: 247-253
Takeuchi, S.; Fukui, I.; Higashi, Y.; Andoh, M.; Kihara, K.; Kitahara, S.; Horiuchi, S.; Oshima, H. 1989: Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(9): 1513-1517
English, H.F.; Heitjan, D.F.; Lancaster, S.; Santen, R.J. 1991: Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer Cancer Research 51(7): 1760-1765
Küss, R.; Khoury, S.; Richard, F.; Fourcade, R.; Frantz, P.; Capelle, J.P. 1978: Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide La Nouvelle Presse Medicale 7(28): 2478-2479
Muggia, F.M.; Norris, K. 1989: Future of cancer chemotherapy with cisplatin Seminars in Oncology 16(4 Suppl 6: 123-128
Tanneberger, S. 1990: Cancer chemotherapy today and in the future Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(23): 693-695
Sakamoto, S.; Kusuyama, H.; Numa, H.; Okada, K. 1989: Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case Hinyokika Kiyo. Acta Urologica Japonica 35(6): 1069-1073
Fujiwara, K. 2015: Current and future trend of chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(2): 164-165
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Imai, H.; Ishioka, C. 2015: Present status and future prospect of the chemotherapy for ampullary cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 3): 737-740
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Ozols, R.F.; Vermorken, J.B. 1997: Chemotherapy of advanced ovarian cancer: current status and future directions Seminars in Oncology 24(1 Suppl 2: S2
Osaki, A.; Saeki, T. 2007: Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 407-413
Takahashi, K.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Arai, K.; Iwasaki, Y.; Katayanagi, S. 2004: The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(Suppl 2): 154-156
Yagoda, A. 1977: Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer Cancer Research 37(8 Part 2): 2775-2780
Yokoyama, J. 2002: Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 169-175
Niho, S.; Motegi, A.; Akimoto, T. 2015: Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(2): 144-147